Search Results for gallbladder

Showing 1 – 1

FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi By Zachary Brennan - Published 15 March 2017

Following the death of two patients without a gallbladder on Allergan’s irritable bowel drug Viberzi (eluxadoline), the US Food and Drug Administration (FDA) on Wednesday warned about the increased risk of serious pancreatitis in such patients.

Categories: News, US, FDA, Crisis management, Drugs, Postmarket surveillance

Tags: Viberzi, pancreatitis, Viberzi deaths, gallbladder